Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel F Martin

Showing results (91-100 of 116) with videos related to

Pageof 12
Sort By:
JAMA Ophthalmology|May 31, 2014
Sustained visual acuity loss in the comparison of age-related macular degeneration treatments trialsGui-shuang Ying, Benjamin J Kim, Maureen G Maguire, et al.
Ophthalmology|October 14, 2014
Outcomes of eyes with lesions composed of >50% blood in the Comparison of Age-related Macular Degeneration Treatments Trials (CATT)Michael M Altaweel, Ebenezer Daniel, Daniel F Martin, et al.
The British Journal of Ophthalmology|December 4, 2016
Comparison of anti-VEGF therapies on fibrovascular pigment epithelial detachments in age-related macular degenerationAdrian Au, Vishal S Parikh, Rishi P Singh, et al.
Ophthalmology. Retina|May 4, 2019
Linking OCT, Angiographic, and Photographic Lesion Components in Neovascular Age-Related Macular DegenerationCynthia A Toth, Vincent Tai, Stephanie J Chiu, et al.
Ophthalmology. Retina|May 4, 2019
Long-Term Assessment of Macular Atrophy in Patients with Age-Related Macular Degeneration Receiving Anti-Vascular Endothelial Growth FactorAng Li, Nathaniel B Rieveschl, Felipe F Conti, et al.
Ophthalmology|February 9, 2024
Risk Factors for Meeting Criteria for Switching from Bevacizumab to Aflibercept When Treating Eyes with Diabetic Macular Edema and Visual Acuity of < 20/40Chirag D Jhaveri, Danni Liu, Maureen G Maguire, et al.
JAMA|December 15, 2020
Effect of Intravitreous Aflibercept vs Vitrectomy With Panretinal Photocoagulation on Visual Acuity in Patients With Vitreous Hemorrhage From Proliferative Diabetic Retinopathy: A Randomized Clinical TrialAndrew N Antoszyk, Adam R Glassman, Wesley T Beaulieu, et al.
Ophthalmology|October 3, 2013
Risk of geographic atrophy in the comparison of age-related macular degeneration treatments trialsJuan E Grunwald, Ebenezer Daniel, Jiayan Huang, et al.
JAMA|May 1, 2019
Effect of Initial Management With Aflibercept vs Laser Photocoagulation vs Observation on Vision Loss Among Patients With Diabetic Macular Edema Involving the Center of the Macula and Good Visual Acuity: A Randomized Clinical TrialCarl W Baker, Adam R Glassman, Wesley T Beaulieu, et al.
Ophthalmology|May 28, 2013
Incidence of choroidal neovascularization in the fellow eye in the comparison of age-related macular degeneration treatments trialsMaureen G Maguire, Ebenezer Daniel, Ankoor R Shah, et al.
Pageof 12

Showing results (91-100 of 116) with videos related to

Sort By:
Pageof 12
JAMA Ophthalmology|May 31, 2014
Sustained visual acuity loss in the comparison of age-related macular degeneration treatments trialsGui-shuang Ying, Benjamin J Kim, Maureen G Maguire, et al.
Ophthalmology|October 14, 2014
Outcomes of eyes with lesions composed of >50% blood in the Comparison of Age-related Macular Degeneration Treatments Trials (CATT)Michael M Altaweel, Ebenezer Daniel, Daniel F Martin, et al.
The British Journal of Ophthalmology|December 4, 2016
Comparison of anti-VEGF therapies on fibrovascular pigment epithelial detachments in age-related macular degenerationAdrian Au, Vishal S Parikh, Rishi P Singh, et al.
Ophthalmology. Retina|May 4, 2019
Linking OCT, Angiographic, and Photographic Lesion Components in Neovascular Age-Related Macular DegenerationCynthia A Toth, Vincent Tai, Stephanie J Chiu, et al.
Ophthalmology. Retina|May 4, 2019
Long-Term Assessment of Macular Atrophy in Patients with Age-Related Macular Degeneration Receiving Anti-Vascular Endothelial Growth FactorAng Li, Nathaniel B Rieveschl, Felipe F Conti, et al.
Ophthalmology|February 9, 2024
Risk Factors for Meeting Criteria for Switching from Bevacizumab to Aflibercept When Treating Eyes with Diabetic Macular Edema and Visual Acuity of < 20/40Chirag D Jhaveri, Danni Liu, Maureen G Maguire, et al.
JAMA|December 15, 2020
Effect of Intravitreous Aflibercept vs Vitrectomy With Panretinal Photocoagulation on Visual Acuity in Patients With Vitreous Hemorrhage From Proliferative Diabetic Retinopathy: A Randomized Clinical TrialAndrew N Antoszyk, Adam R Glassman, Wesley T Beaulieu, et al.
Ophthalmology|October 3, 2013
Risk of geographic atrophy in the comparison of age-related macular degeneration treatments trialsJuan E Grunwald, Ebenezer Daniel, Jiayan Huang, et al.
JAMA|May 1, 2019
Effect of Initial Management With Aflibercept vs Laser Photocoagulation vs Observation on Vision Loss Among Patients With Diabetic Macular Edema Involving the Center of the Macula and Good Visual Acuity: A Randomized Clinical TrialCarl W Baker, Adam R Glassman, Wesley T Beaulieu, et al.
Ophthalmology|May 28, 2013
Incidence of choroidal neovascularization in the fellow eye in the comparison of age-related macular degeneration treatments trialsMaureen G Maguire, Ebenezer Daniel, Ankoor R Shah, et al.
Pageof 12